Cinclus Pharma
Research based biotech company developing small molecules for the treatment of gastric acid related diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD206m (Public information from May 2022)
Company register number 559136-8765
Stockholms kommun Stockholm County (HQ)
Financials
Estimates*
| EUR | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | - | <1m | 1.3m |
| % growth | - | - | 39 % |
| EBITDA | (8.2m) | (19.0m) | - |
| % EBITDA margin | - | (2001 %) | - |
| Profit | (7.5m) | (22.4m) | - |
| % profit margin | - | (2356 %) | - |
| R&D budget | 6.8m | 14.1m | - |
| R&D % of revenue | - | 1487 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
SEK250m | Late VC | ||
* | SEK240m Valuation: SEK1.3b -16.7x EV/LTM EBITDA | Private Placement VC | |
| Total Funding | CAD80.9m | ||
Related Content
Recent News about Cinclus Pharma
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.